Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date ...
During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...
4don MSNOpinion
Opinion - How a pandemic rescue became a 30-year debt trap
Millions of small businesses are discovering that the emergency fiscal help they relied on in 2020 came with a long tail of ...
Bionic Biologics represent a novel therapeutic modality that integrates principles of biologic and synthetic design. This innovative platform enables the targeting of well-validated yet previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback